Literature DB >> 26339376

Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.

Daqing Shen1, Xianxiang Cao1.   

Abstract

AIM: To investigate the potential role of CXCR3 expression on prostate cancer cell proliferation and invasion and to illustrate its mechanism.
METHODS: Human PC-3 cells were transfected with siRNA-CXCR3A and siRNA-CXCR3B plasmids respectively. The mRNA expressions of CXCR3A and CXCR3B in PC-3 cells from each group were analyzed using RT-PCR. Besides, cell proliferation ability and cell invasion ability of PC-3 cells in each group were analyzed using MTT assay and Matrige assay respectively. Additionally, expressions of CXCR3 downstream proteins were detected using Western blotting.
RESULTS: mRNA level of CXCR3A was decreased while CXCR3B mRNA level was increased in PC-3 cells (P<0.05). Compared with the controls, down-regulation of CXCR3A but up-regulation of CXCR3B significantly inhibited PC-3 cell proliferation and cell invasion ability (P<0.05). Besides, aberrant CXCR3 expression significantly increased expressions of phospholipase C (PLCβ), matrix metallo proteinase (MMP-1), and MMP-3 except MMP-7 in PC-3 cells (P<0.05).
CONCLUSION: The data presented in our study suggested that aberrant CXCR3 expression may play crucial roles in suppressing PC metastasis via inhibiting cell proliferation and invasion ability through the PCLβ signaling pathway.

Entities:  

Keywords:  PC-3 cell line; Prostate cancer; cell invasion; cell proliferation; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26339376      PMCID: PMC4555704     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  34 in total

1.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

2.  Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.

Authors:  Michael J Zelefsky; Xin Pei; Joanne F Chou; Michael Schechter; Marisa Kollmeier; Brett Cox; Yoshiya Yamada; Anthony Fidaleo; Dahlia Sperling; Laura Happersett; Zhigang Zhang
Journal:  Eur Urol       Date:  2011-08-22       Impact factor: 20.096

3.  RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line.

Authors:  Liping Ou; Yongcan Guo; Chunli Luo; Xiaohou Wu; Yi Zhao; Xiaozhong Cai
Journal:  Cancer Genet Cytogenet       Date:  2010-07-15

4.  Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.

Authors:  Dipak Datta; Jesse A Flaxenburg; Sreenivas Laxmanan; Christopher Geehan; Martin Grimm; Ana Maria Waaga-Gasser; David M Briscoe; Soumitro Pal
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

5.  Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.

Authors:  Tonya C Walser; Salah Rifat; Xinrong Ma; Namita Kundu; Chris Ward; Olga Goloubeva; Michael G Johnson; Julio C Medina; Tassie L Collins; Amy M Fulton
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

6.  PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.

Authors:  Natasa Obermajer; Ravikumar Muthuswamy; Kunle Odunsi; Robert P Edwards; Pawel Kalinski
Journal:  Cancer Res       Date:  2011-10-24       Impact factor: 12.701

7.  Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.

Authors:  Hidekazu Sugasawa; Takashi Ichikura; Manabu Kinoshita; Satoshi Ono; Takashi Majima; Hironori Tsujimoto; Kentaro Chochi; Sadayuki Hiroi; Eiji Takayama; Daizoh Saitoh; Shuhji Seki; Hidetaka Mochizuki
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

8.  Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome.

Authors:  Davide Bedognetti; Ena Wang; Francesco M Marincola
Journal:  Oncoimmunology       Date:  2014-04-09       Impact factor: 8.110

9.  CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3.

Authors:  Anja Mueller; Andrea Meiser; Ellen M McDonagh; James M Fox; Sarah J Petit; Georgina Xanthou; Timothy J Williams; James E Pease
Journal:  J Leukoc Biol       Date:  2008-01-03       Impact factor: 4.962

10.  Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.

Authors:  J Panse; K Friedrichs; A Marx; Y Hildebrandt; T Luetkens; K Barrels; C Horn; T Stahl; Y Cao; K Milde-Langosch; A Niendorf; N Kröger; S Wenzel; R Leuwer; C Bokemeyer; S Hegewisch-Becker; D Atanackovic
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

View more
  5 in total

1.  C-X-C motif receptor 3A enhances proliferation and invasiveness of colorectal cancer cells, and is mediated by C-X-C motif ligand 10.

Authors:  Eriko Nozaki; Takaaki Kobayashi; Hiroaki Ohnishi; Kouki Ohtsuka; Tadahiko Masaki; Takashi Watanabe; Masanori Sugiyama
Journal:  Oncol Lett       Date:  2020-01-21       Impact factor: 2.967

2.  Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer.

Authors:  Fangfang Chen; Jingping Yuan; Honglin Yan; Huan Liu; Shuai Yin
Journal:  Biomed Res Int       Date:  2019-05-21       Impact factor: 3.411

3.  Effect of Vitamin D3 on Lung Damage Induced by Cigarette Smoke in Mice.

Authors:  Xin Zheng; Nini Qu; Lina Wang; Guoli Wang; Rui Jiao; Hu Deng; Sijia Li; Yibing Qin
Journal:  Open Med (Wars)       Date:  2019-11-07

4.  Computer-aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma.

Authors:  Xiao Yu; Wei Lu; Chan Way Ng; Shuoyu Xu; Yao Wu; Shili Chen; Yuren Gao; Yijian Zhang; Qingqing Zhang; Yuzhen Xu; Yingbin Liu; Sheng Li
Journal:  J Cell Mol Med       Date:  2020-06-08       Impact factor: 5.310

5.  CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer.

Authors:  Naoya Nagaya; Geun Taek Lee; Shigeo Horie; Isaac Yi Kim
Journal:  Front Mol Biosci       Date:  2020-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.